Your various posts from within the hive mind mentality here, merely validates my actions to date.
And how Northwest BioTherapeutics is not in any fit to be a supplier of cancer treatments to the NHS, who judge such companies in the round.
I one thing that the NHS requires, in such a critical sector, is the stability of operation of that provider.
Our Healthcare System has never been the clinical wild-west, for any opportunistic entities looking to raid its limited funds with, as yet, unproven treatment efficacy ( the nod from an online magazine does not substitute any regulatory due-diligence or forensic analysis ).